- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Peak sales per new pharmaceutical asset 2010-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Peak sales per new pharmaceutical asset 2010-2018
Peak sales for each new pharmaceutical asset from 2010 to 2018, by study cohort (in million U.S. dollars)
by Matej Mikulic,
last edited
Jan 4, 2019
This statistic shows the average peak sales amount per new pharmaceutical pipeline asset from 2010 to 2018, in million U.S. dollars. In the original study cohort the average peak sales per asset dropped from 816 million U.S. dollars in 2010 to 400 million U.S. dollars in 2016.
Peak sales for each new pharmaceutical asset from 2010 to 2018, by study cohort (in million U.S. dollars)
| Mean original cohort | Mean extension cohort | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| Mean original cohort | Mean extension cohort | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jan 4, 2019
This statistic shows the average peak sales amount per new pharmaceutical pipeline asset from 2010 to 2018, in million U.S. dollars. In the original study cohort the average peak sales per asset dropped from 816 million U.S. dollars in 2010 to 400 million U.S. dollars in 2016.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2018
- Region
- Worldwide
- Survey time period
- 2010 to 2018
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2018
More information
- Region
- Worldwide
- Survey time period
- 2010 to 2018
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
Pharmaceutical Products & Market
Market share of generics in European countries 2017
+Pharmaceutical Products & Market
Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)Leading European pharmaceutical companies by R&D spending 2018
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Revenue forecast for global biologics market 2016-2022
- Operating profit/loss (EBIT) of Sobi 2007-2017
- Gross profit of Sobi 2007-2017
- Number of employees at Sobi 2013-2017
- Latin America: biopharmaceuticals revenue 2018-2023
- Gross margin of Sobi 2007-2017
- Number of geriatric drugs that had retail price increase in the U.S. 2017
- Drug products patented sales in Canada by therapeutic class 2017
- Price increase top 5 geriatric drugs in the U.S. in 2017
- Total worldwide prescription drug revenue growth - projection 2019-2024
- Global biopharma non-cold chain product sales 2016-2022
- Pharmaceutical sales in Canada 2004-2017
- Patented drug products annual sales change in Canada 1991-2017
- Annual compensation in U.S. biopharmaceutical industry vs. national average 2015
- Specialty drug spending growth characteristics in the U.S. 2012-2017
- Number of biopharmaceutical industry-sponsored clinical trials U.S. 2013, by phase
- Orphan drug spending growth characteristics in the U.S. 2012-2017
- Number of biopharmaceutical clinical trial participants in the U.S. 2013, by phase
- Market share of orphan drugs valued <$6,000 per year in 2017, by therapy class
- Global biopharma logistics spending breakdown by type 2016
Studies
- Pharmaceutical industry in Italy
- Biotechnology in Germany
- Pharmaceutical trends in Europe
- Biotechnology Industry in Europe
- 2019 PhRMA Annual Membership Survey
- The Changing Face of Global Clinical Trials
- 2018 PhRMA Annual Membership Survey
- Global Participation in Clinical Trials Report 2015-2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
- Biopharmaceutical Industry-Sponsored Clinical Trials: Impact on State Economies
- PhRMA 2015 Biopharmaceutical Research Industry Profile
- PhRMA 2016 Biopharmaceutical Research Industry Profile
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018
- Market share of generics in selected European countries as of 2017
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Projected annual global biologics revenue from 2016 to 2022 (in billion U.S. dollars)
- Operating profit/loss (EBIT) of Sobi from 2007 to 2017 (in million SEK)
- Gross profit of Sobi from 2007 to 2017 (in million SEK)
- Number of employees at Sobi from 2013 to 2017
- Biopharmaceuticals market value in Latin America in 2018 and 2023 (in billion U.S. dollars)
- Gross margin of Sobi from 2007 to 2017
- Number of drugs mostly used by older U.S. adults that had a select retail price increase during 2017*
- Patented drug products sales in Canada in 2017, by therapeutic class (in million Canadian dollars)*
- Price increase among top five brand name drugs widely used by older U.S. adults during 2017*
- Projected worldwide total prescription drug revenue growth from 2019 to 2024
- Global biopharma non-cold chain product sales from 2016 to 2022 (in billion U.S. dollars)
- Total pharmaceutical sales in Canada from 2004 to 2017 (in billion Canadian dollars)
- Patented drug products annual sales change in Canada from 1991 to 2017
- Average annual compensation in the U.S. biopharmaceutical industry vs. national average in 2015 (in U.S. dollars)*
- Specialty drug market growth characteristics in the U.S. between 2012 and 2017 (in billion U.S. dollars)
- Number of biopharmaceutical industry-sponsored clinical trials in the United States in 2013, by phase
- Orphan drug market growth characteristics in the U.S. between 2012 and 2017 (in billion U.S. dollars)
- Number of participants in biopharmaceutical clinical trials in the United States in 2013, by phase
- Market share of orphan drugs that cost patients less than $6,000 per year in 2017, by therapy class
- Breakdown of the biopharma logistics spending in 2016, by type (in billion U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.